Vincent Zurawski has been named CEO of the US subsidiary of Compugen.
Zurawski will direct Compugen’s US operations, based in Princeton, N.J. He will also help develop and implement Compugen’s worldwide business strategy and lead the business and product development of the company’s drug discovery activities.
Following the co-founding of Centocor, a biotechnology company which was recently purchased by Johnson & Johnson, Zurawski founded and was CEO of Apollon, a developer of DNA-based vaccines.
Most recently, Zurawski served as director of research business development at the University of Pennsylvania School of Medicine and Health System, where he was responsible for commercializing intellectual property.